Upgrade to SI Premium - Free Trial

Neogenomics (NEO) PT Lowered to $21 at BTIG

May 2, 2024 5:24 AM
BTIG analyst Mark Massaro lowered the price target on Neogenomics (NASDAQ: NEO) to $21.00 (from $23.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles